You are on page 1of 22

CASE PRESENTATION ON IMMEDIATE

POST OPERATION DAY AFTER


APPENDECTOMY WAS DONE FOR THE
INDICATION OF ACUTE APPENDICTIS

BY:MISGANA ZEMEDE ID 4326/06


Patient detail
2

 Name: B.M Date of admission:11/07/10


 Age: 11 Address: Haramaya
 Sex: female card no :413257
 BED NO 34
 Ethnicity: oromo
 Religion : muslim

07/23/2023
Patient detail…
3

c/c – Abdominal pain of 5 days duration

HPI- she was relatively healthy 05 days back at


which time she started to experience crampy
type of abdominal pain which occur at the
amblical later become at RL abdomen, in
associated to these she was Hx of Anorexia,
Nausea, loss of appetite and LGIF.

07/23/2023
Patient detail…
4

Other wise
she has no hx of Vomiting, failure to pass faces.
No hx of diarrhea
PMH – she has no hx of DM,HTN, & kidney disease .

Medication history - no past medication history

FH – she has no self & family hx of chronic disease.

SH – she is elementary school student and lives with her father


and mother.

07/23/2023
Patient detail…
5

Drug allergy – She has no hx of drug allergy

ADR – She has no hx of ADR

07/23/2023
6

Day Pulse BP RR Temperatur SPO2


e

11/07/10 104 114/67 24 37.8 92 on O2

12/07/10 116 110/70 30 37.1 94 on O2

16/07/10 96 110/70 26 37 93 on O2

07/23/2023
Physical examination
7

G/A - well Looking

HEENT – pink conjunctiva

RS – clear chest with good air entry

CVS – s1& s2 well heard, No M and G

07/23/2023
Con…
8

Abdomen – Flat moves with respiration, No


sign of fluid collection
There is direct tenderness over RLQ
IGS – No rash
MSS – No deformity and no edema
GUS – No CVAT
CNS -COPPT

07/23/2023
Investigations
9

 WBC= 10.04 Neutro= 65


 RBC= 5.16 Lympho= 21
 HGB= 14.2 Basophl= 14
 HCT= 41.5 RDW= 12.9
 MCV= 80.4

 Ultra sound report: RLQ pericecal inflammatory


change with thick collection likely 2ndry to ruptured
appendix.
07/23/2023
Assessment
10

IMMEDIATE POST OPERATION DAY


AFTER
APPENDECTOMY WAS DONE FOR
THE INDICATION OF ACUTE
APPENDICTIS

07/23/2023
Drug therapy
11

 Ceftriaxone 750mg IV BID

 Diclofenac 50 mg IM BID

 MF = 850ml/12hr which contains


85 ml of D40
482ml of D5
283ml of N/S

07/23/2023
Discussion AND CRITIQUE OF
CURRENT Treatment
12

Appendicitis, is an inflammation of the vestigial vermiform


appendix, is one of the most common causes of the acute


abdomen and one of the most frequent indications for an
emergent abdominal surgical procedure worldwide.
The appendix is a true diverticulum of the cecum.

Appendiceal obstruction has been proposed as the primary


cause of appendicitis

07/23/2023

13

 Appendiceal obstruction may be caused by


fecaliths (hard fecal masses), calculi, lymphoid
hyperplasia, infectious processes, and benign
or malignant tumors.

 Common organisms involved in gangrenous


and perforated appendicitis include
Escherichia coli, Peptostreptococcus,
Bacteroides fragilis, and Pseudomonas species

07/23/2023

14

Clinical manifestations
Right lower quadrant (right anterior iliac fossa) abdominal

pain
Anorexia

Nausea and vomiting


Treatment
Surgery is the mainstay of treatment and it’s process is

known as Appendectomy

07/23/2023
15

Non operative treatment includes the following:

 Intravenous fluids should be administered. Oral


intake may be resumed as tolerated.

 Parenteral nutrition is indicated if the child is


unable to eat after one week.

07/23/2023

16

 Antibiotics should be prescribed (as for


advanced appendicitis) and continued until
the child is afebrile, tolerating a regular diet,
and has a normal WBC.

 Appropriate pain management

07/23/2023
Pharmacotherapeutic plan
17

Goal of therapy

 For preventing post operative complications of


perforated appendicitis.
 To prevent or reduce recurrence (re-infection)
rate of Appendicitis.
 To correct electrolyte abnormalities
 Minimize hospitalization

07/23/2023
18

 There is Drug Therapy Problem/DTP/

Needs Additional Drug Therapy

Metronidazole 500mg IV,TID is require as


appendicitis is raptured or perforated to cover
anaerobic pathogen we should be give
metronidazole with Ceftriaxone as treatment.

07/23/2023

19

Care plan

 To continue the above medication with good


adherence of the patient.

 To monitor and evaluate the ADR of the drug.

07/23/2023
Monitoring parameter
20

 Vital signs
such as Pulse, BP, RR and Temperature

 Oxygen saturation

 Wound site infection

 Sign and Symptoms

 Appetite of the patient 07/23/2023


Patient education
21

 I counsel the care giver to ambulate the patient to


prevent the occurrence of DVT.
 I counsel the care giver to limit the physical
activity of the patient to make the healing of the
tissue to be faster.
 I counsel on fiber containing meals for the patient
such as vegetables like cabbage.
 I counsel the care giver to offer clear liquids the
day after surgery until she progress to a regular
diet.
07/23/2023
22

THANK

YOU!!!!!!
07/23/2023

You might also like